ReviewMedicine2026
A fatal case of ANCA-associated vasculitis resulting in multiple organ failure: Case report and literature review.
Review in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) may progress rapidly to multi-organ failure. CASE: An 89-year-old woman with diabetes, atrial fibrillation (on rivaroxaban), and chronic kidney disease presented with hemoptysis and respiratory failure. Initially managed as pneumonia, she developed diffuse alveolar hemorrhage, acute kidney injury, and liver dysfunction. p-ANCA positivity confirmed AAV, but immunosuppressive therapy was deferred due to septic shock. Despite aggressive supportive care, she died from multi-organ failure on day 12.
conclusionAAV should be considered in elderly patients with hemoptysis and rapid multi-organ deterioration. Early diagnosis and cautious immunosuppressive use are essential for improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.